ANDHealth & Novartis – Shaping The Future of Digital Health
Date: Wednesday 20th February 2019
Time: 9:30am-11:00am followed by Networking Drinks
Location: Novartis Pharmaceuticals Australia- 54 Waterloo Rd, Macquarie Park NSW 2113
Cost: Free- Spaces are limited
ANDHealth and Novartis are delighted to welcome international digital health leader Lisa Suennen, Digital & Technology Group Lead, Manatt Ventures.
Keynote Speaker: Lisa Suennen
Lead, Digital & Technology business and Lead, Manatt Ventures
Named 2018 Top Digital Health Evangelist by Goldman Sachs, Rock Health, Fenwick and West & Square 1 Bank, Lisa has extensive experience in the digital health sector which can be viewed at https://venturevalkyrie.com/about/. Lisa is a renowned venture capital investor in digital health a published author, co-founder of CSweetener, host of Tech Tonics Podcast (iTunes), a faculty member of UC Berkley Haas School of Businesses, chair of the NASA Translational Research Institute, member of the Advisory Council of State of California Initiative to Advance Precision Medicine, and all round “Tech Superwoman” (Forbes).
As a foundation member and ANDHealth’s exclusive pharmaceutical partner, Novartis is working with ANDHealth to advance the commercialisation of evidence-based digital health technologies in Australia, to change the way we deliver healthcare and to provide patients with better health outcomes.
Join us for an overview on international and national perspectives on digital health, how national programs are supporting the sector, and the impact of digital health technologies on patient care.
Raghav Murali-Ganesh, Co-Founder, CancerAid
Lisa Suennen, Digital & Technology Group Lead, Manatt Ventures
Lisa Suennen and Bronwyn Le Grice (Interviewed by Adam Wardell, Novartis)